quipt_sc13g.htm

SC 13G 1 quipt_sc13g.htm SC 13G quipt_sc13g.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. __)*

Quipt Home Medical Corp.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

74880P104

(CUSIP Number)

June 6, 2024

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

	☐	Rule 13d-1(b)

	☒	Rule 13d-1(c)

	☐	Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 74880P104

Page 2 of 7 Pages

NAME OF REPORTING PERSONS

Forager Fund, L.P.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a) ☐ (b) ☐

SEC USE ONLY

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF

BENEFICIALLY

OWNED BY EACH REPORTING

PERSON

WITH

SOLE VOTING POWER

2,129,970

SHARED VOTING POWER

SOLE DISPOSITIVE POWER

2,129,970

SHARED DISPOSITIVE POWER

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

2,129,970

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)

☐

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

5.0%⁽¹⁾

TYPE OF REPORTING PERSON (See Instructions)

(1)	Calculated based on 42,571,000 shares of common stock of the Issuer as of March 31, 2024, as reported on the Issuer’s Report of Foreign Private Issuer on Form 6-K for the period ended March 31, 2024, filed on May 15, 2024.

CUSIP No. 74880P104

Page 3 of 7 Pages

NAME OF REPORTING PERSONS

Forager Capital Management, LLC

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a) ☐ (b) ☐

SEC USE ONLY

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF

BENEFICIALLY

OWNED BY EACH REPORTING

PERSON

WITH

SOLE VOTING POWER

2,129,970⁽¹⁾

SHARED VOTING POWER

SOLE DISPOSITIVE POWER

2,129,970⁽¹⁾

SHARED DISPOSITIVE POWER

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

2,129,970⁽¹⁾

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)

☐

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

5.0%⁽²⁾

TYPE OF REPORTING PERSON (See Instructions)

(1)	Shares reported in this table are held by Forager Fund, L.P., of which the Reporting Person is the general partner.
(2)	Calculated based on 42,571,000 shares of common stock of the Issuer as of March 31, 2024, as reported on the Issuer’s Report of Foreign Private Issuer on Form 6-K for the period ended March 31, 2024, filed on May 15, 2024.

CUSIP No. 74880P104

Page 4 of 7 Pages

NAME OF REPORTING PERSONS

Edward Kissel

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a) ☐ (b) ☐

SEC USE ONLY

CITIZENSHIP OR PLACE OF ORGANIZATION

USA

NUMBER OF

BENEFICIALLY

OWNED BY EACH REPORTING

PERSON

WITH

SOLE VOTING POWER

SHARED VOTING POWER

2,129,970⁽¹⁾

SOLE DISPOSITIVE POWER

SHARED DISPOSITIVE POWER

2,129,970⁽¹⁾

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

2,129,970⁽¹⁾

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)

☐

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

5.0%⁽²⁾

TYPE OF REPORTING PERSON (See Instructions)

HC; IN

(1)	These shares are held by Forager Fund, L.P., of which Forager Capital Management, LLC is the general partner. The Reporting Person is a managing partner of Forager Capital Management, LLC.
(2)	Calculated based on 42,571,000 shares of common stock of the Issuer as of March 31, 2024, as reported on the Issuer’s Report of Foreign Private Issuer on Form 6-K for the period ended March 31, 2024, filed on May 15, 2024.

CUSIP No. 74880P104

Page 5 of 7 Pages

NAME OF REPORTING PERSONS

Robert MacArthur

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a) ☐ (b)☐

SEC USE ONLY

CITIZENSHIP OR PLACE OF ORGANIZATION

USA

NUMBER OF

BENEFICIALLY

OWNED BY EACH REPORTING

PERSON

WITH

SOLE VOTING POWER

SHARED VOTING POWER

2,129,970⁽¹⁾

SOLE DISPOSITIVE POWER

SHARED DISPOSITIVE POWER

2,129,970⁽¹⁾

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

2,129,970⁽¹⁾

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)

☐

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

5.0%⁽²⁾

TYPE OF REPORTING PERSON (See Instructions)

HC; IN

(1)	These shares are held by Forager Fund, L.P., of which Forager Capital Management, LLC is the general partner. The Reporting Person is a managing partner of Forager Capital Management, LLC.
(2)	Calculated based on 42,571,000 shares of common stock of the Issuer as of March 31, 2024, as reported on the Issuer’s Report of Foreign Private Issuer on Form 6-K for the period ended March 31, 2024, filed on May 15, 2024.

CUSIP No. 74880P104

Page 6 of 7 Pages

ITEM 1(a).	NAME OF ISSUER

	Quipt Home Medical Corp. (the “Issuer”)

ITEM 1(b).	ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES

	1019 Town Drive Wilder, Kentucky 41076

ITEM 2(a).	NAME OF PERSONS FILING

	This joint statement on Schedule 13G is being filed by Forager Fund, L.P., a Delaware limited partnership (the “Fund”), Forager Capital Management, LLC, a Delaware limited liability company and the general partner of the Fund (the “General Partner”), Edward Kissel and Robert MacArthur (collectively, the “Reporting Persons”).

	The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed as Exhibit 1 to this Schedule 13G, pursuant to which they have agreed to file this Schedule 13G jointly in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.

ITEM 2(b).	ADDRESS OF PRINCIPAL BUSINESS OFFICE

	The business address of each of the Reporting Persons is 2025 3rd Ave. N, Suite 350, Birmingham, AL 35203.

ITEM 2(c).	CITIZENSHIP

	The Fund is a Delaware limited partnership. The General Partner is a Delaware limited liability company. Each of Messrs. Kissel and MacArthur is a citizen of the United States.

ITEM 2(d).	TITLE OF CLASS OF SECURITIES

	Common stock (the “Common Stock”).

ITEM 2(e).	CUSIP NUMBER

	74880P104

ITEM 3.	Not applicable.

ITEM 4.	OWNERSHIP

	The Reporting Persons, in the aggregate, beneficially own 2,129,970 shares of Common Stock of the Issuer, representing approximately 5.0% of such class of securities. The beneficial ownership of each Reporting Person is as follows: each of the Fund, the General Partner and Messrs. Kissel and MacArthur beneficially owns 2,129,970 shares of Common Stock representing approximately 5.0% of the class. The percentages of beneficial ownership reported herein, and on each Reporting Person’s cover page to this Schedule 13G, are based on a total of 42,571,000 shares of Common Stock as of March 31, 2024, as reported on the Issuer’s Report of Foreign Private Issuer on Form 6-K for the period ended March 31, 2024, filed on May 15, 2024.

CUSIP No. 74880P104

Page 7 of 7 Pages

	Each of the Fund and the General Partner has the sole power to vote and dispose of 2,129,970 shares of Common Stock. Each of Messrs. Kissel and MacArthur has the shared power to vote and dispose of 2,129,970 shares of Common Stock. The amounts and percentages of beneficial ownership reported herein are as of June 6, 2024.

ITEM 5.	OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS

	Not applicable.

ITEM 6.	OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON

	Not applicable.

ITEM 7.	IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON

	Not applicable.

ITEM 8.	IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP

	Not applicable.

ITEM 9.	NOTICE OF DISSOLUTION OF GROUP

	Not applicable.

ITEM 10.	CERTIFICATION

	By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

	DATE:	December 11, 2024

	FORAGER FUND, L.P.

	By:	Forager Capital Management, LLC,
		its General Partner

	By:	/s/ Robert MacArthur
		Robert MacArthur
		Managing Partner

	FORAGER CAPITAL MANAGEMENT, LLC

	By:	/s/ Robert MacArthur
		Robert MacArthur
		Managing Partner

	EDWARD KISSEL

	/s/ Edward Kissel
	Edward Kissel

	ROBERT MACARTHUR

	/s/ Robert MacArthur
	Robert MacArthur

Exhibit 1

JOINT FILING AGREEMENT

Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree, as of December 11, 2024, that only one statement containing the information required by Schedule 13G, and each amendment thereto, need be filed with respect to the ownership by each of the undersigned of shares of common stock of Quipt Home Medical Corp., a British Columbia, Canada corporation, and such statement to which this Joint Filing Agreement is attached as Exhibit 1 is filed on behalf of each of the undersigned.

	FORAGER FUND, L.P.

	By:	Forager Capital Management, LLC,
		its General Partner

	By:	/s/ Robert MacArthur
		Robert MacArthur
		Managing Partner

	FORAGER CAPITAL MANAGEMENT, LLC

	By:	/s/ Robert MacArthur
		Robert MacArthur
		Managing Partner

	EDWARD KISSEL

	/s/ Edward Kissel
	Edward Kissel

	ROBERT MACARTHUR

	/s/ Robert MacArthur
	Robert MacArthur

Exhibit 2

CONFIRMING STATEMENT

This Statement confirms that the undersigned has authorized and designated Robert MacArthur to execute and file on the undersigned’s behalf all Forms 3, 4 and 5 and Schedules 13D and 13G (including any amendments thereto) that the undersigned may be required to file with the U.S. Securities and Exchange Commission as a result of the undersigned’s ownership of or transactions in securities of Quipt Home Medical Corp., a British Columbia, Canada corporation. The authority of Robert MacArthur under this Statement shall continue until the undersigned is no longer required to file any of Forms 3, 4 and 5 and Schedules 13D and 13G with regard to the undersigned’s ownership of or transactions in securities of Regional Management Corp., unless earlier revoked in writing. The undersigned acknowledges that Robert MacArthur is not assuming any of the undersigned’s responsibilities to comply with Section 16 or Section 13 of the Securities Exchange Act of 1934, as amended.

Dated: December 11, 2024		/s/ Edward Kissel
		Edward Kissel

Exhibit 3

CONFIRMING STATEMENT

This Statement confirms that the undersigned has authorized and designated Edward Kissel to execute and file on the undersigned’s behalf all Forms 3, 4 and 5 and Schedules 13D and 13G (including any amendments thereto) that the undersigned may be required to file with the U.S. Securities and Exchange Commission as a result of the undersigned’s ownership of or transactions in securities of Quipt Home Medical Corp., a British Columbia, Canada corporation. The authority of Edward Kissel under this Statement shall continue until the undersigned is no longer required to file any of Forms 3, 4 and 5 and Schedules 13D and 13G with regard to the undersigned’s ownership of or transactions in securities of Regional Management Corp., unless earlier revoked in writing. The undersigned acknowledges that Edward Kissel is not assuming any of the undersigned’s responsibilities to comply with Section 16 or Section 13 of the Securities Exchange Act of 1934, as amended.

Dated: December 11, 2024		/s/ Robert MacArthur
		Robert MacArthur

SEC Form SC 13G filed by Quipt Home Medical Corp.